A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy
ATTRibute-CM 研究的简明语言综述:acoramidis 治疗转甲状腺素蛋白淀粉样变性心肌病的疗效和安全性
期刊:Future Cardiology
影响因子:1
doi:10.1080/14796678.2025.2591426
Gillmore, Julian D; Judge, Daniel P; Cappelli, Francesco; Fontana, Marianna; Garcia-Pavia, Pablo; Gibbs, Simon; Grogan, Martha; Hanna, Mazen; Hoffman, James; Masri, Ahmad; Maurer, Mathew S; Nativi-Nicolau, Jose; Obici, Laura; Poulsen, Steen Hvitfeldt; Rockhold, Frank; Shah, Keyur B; Soman, Prem; Garg, Jyotsna; Chiswell, Karen; Xu, Haolin; Cao, Xiaofan; Lystig, Ted; Sinha, Uma; Fox, Jonathan C